Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$1.03 - $1.75 $430,844 - $732,018
-418,296 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$1.18 - $1.91 $47,200 - $76,400
40,000 Added 10.57%
418,296 $786,000
Q4 2018

Jan 31, 2019

BUY
$1.01 - $2.78 $19,631 - $54,034
19,437 Added 5.42%
378,296 $424,000
Q3 2018

Nov 09, 2018

BUY
$1.72 - $2.71 $617,237 - $972,507
358,859 New
358,859 $879,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.